Rosanna Maccari

Rosanna Maccari

Auto-generated profile, based on publicly available information

Rosanna Maccari

Dipartimento Farmaco-Chimico, Facoltà di Farmacia, Università di Messina, Viale SS. Annunziata, 98168 Messina, Italy

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2005 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
RMRosanna Maccari
Rosanna Maccari
RORosaria Ottanà
Rosaria Ottanà
MVMaria Gabriella Vigorita
Maria Gabriella Vigorita

1 April 2005 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
RMRosanna Maccari
Rosanna Maccari
RORosaria Ottanà
Rosaria Ottanà
CCCarmela Curinga
Carmela Curinga
MVMaria Gabriella Vigorita
Maria Gabriella Vigorita
DRDietmar Rakowitz
Dietmar Rakowitz
TLThierry Langer
Thierry Langer

1 August 2007 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
RMRosanna Maccari
Rosanna Maccari
Paolo PaoliPaolo Paoli
Paolo Paoli
RORosaria Ottanà
Rosaria Ottanà
MJMichela Jacomelli
Michela Jacomelli
RCRosella Ciurleo
Rosella Ciurleo
GCGuido Camici
Guido Camici

1 January 2011 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
RMRosanna Maccari
Rosanna Maccari
ACAntonella Del Corso
Antonella Del Corso
MGMarco Giglio
Marco Giglio
Roberta MoschiniRoberta Moschini
Roberta Moschini
Umberto MuraUmberto Mura
Umberto Mura
RORosaria Ottanà
Rosaria Ottanà

1 June 2008 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
RMRosanna Maccari
Rosanna Maccari
RORosaria Ottanà
Rosaria Ottanà
RCRosella Ciurleo
Rosella Ciurleo
DRDietmar Rakowitz
Dietmar Rakowitz
BMBarbara Matuszczak
Barbara Matuszczak
TLThierry Langer
Thierry Langer

1 February 2002 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
RMRosanna Maccari
Rosanna Maccari
RORosaria Ottanà
Rosaria Ottanà
FMFrancesca Monforte
Francesca Monforte
MVMaria Gabriella Vigorita
Maria Gabriella Vigorita
As a result of our search for new isoniazid derivatives with extended spectra of activity, we evaluated the in vitro antimycobacterial activities of isonicotinohydrazides (compounds 2) and their cyanoborane adducts (compounds 3), both obtained by the reaction of isonicotinoylhydrazones (compounds 1) with sodium cyanoborohydride. Most of the tested compounds displayed moderate to high activity against Mycobacterium tuberculosis H37Rv, with MICs ranging from 0.2 to 12.5 μg/ml. In particular, some hydrazides showed activity similar to that of rifampin (MIC = 0.2 μg/ml) and rather low cytotoxicity, so that they were generally shown to possess high safety indices. In contrast, the coordination to a cyanoborane (BH 2 CN) group (compounds 3) in general brought about a decrease in antimycobacterial activity, while cytotoxicity increased. Interestingly, selected compounds 1 to 3, mostly hydrazides (compounds 2), were effective in killing M. tuberculosis growing within macrophages at concentrations in culture medium which were much lower than the corresponding MICs. These compounds also displayed good activity against drug-resistant M. tuberculosis strains.